Close
FINDING CURES TOGETHER<sup>SM</sup>

​Board of Directors Candidate: George D. Demetri, MD

Goals for the AACR: “My goal is to help the AACR serve our community as an all-inclusive environment to break down barriers and enable teamwork required to make breakthrough advances in cancer research. Our tools and technologies have never been better to link fundamental academic discoveries to innovative clinical trials and regulatory science in a virtuous cycle of discovery, development, and dissemination. I feel passionately about our opportunities and collective mission to develop the best science and then ensure that this can be applied most effectively, as well as to train and support the next generation of scientists and physician-investigators to make meaningful benefits for patients and society.”
    
Research Interests: experimental therapeutics; sarcomas; application of novel insights from fundamental molecular biological structural biology research to cancers in patients by developing rationally targeted anticancer therapeutics; development of new systemic approaches targeting specific signaling pathways in molecularly defined subtypes of sarcomas; gastrointestinal stromal tumors (GIST)

Current Affiliations: professor of medicine and director of Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts; director of Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts; senior vice president for experimental therapeutics and staff physician, Dana-Farber Cancer Institute, Boston, Massachusetts; co-associate director of clinical science, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; associate physician, Brigham and Women’s Hospital, Boston, Massachusetts; affiliate physician, Massachusetts General Hospital, Boston, Massachusetts; visiting clinical attending physician, National Cancer Institute, Bethesda, Maryland

Previous Positions: director of Center for Novel Experimental Therapeutics (2010-2013), associate director of Center for Clinical and Translational Research (2005-2008), chief of clinical services (1994-1995), and quality assurance physician coordinator, Ambulatory Services, Department of Medicine (1990-1994), Dana-Farber Cancer Institute; executive director (2005-2008) and associate director (2004-2005), Clinical and Translational Research, Ludwig Institute for Cancer Research; associate professor of medicine (2001-2012) and assistant professor of medicine (1992-2001), Harvard Medical School; associate attending physician, Beth Israel Deaconess Medical Center (1996-2000); associate physician, Massachusetts General Hospital (1994-2002); clinical associate, Somerville Hospital (1987-1991); emergency ward physician, Pacific Medical Center (1985-1986)

Postdoctoral Training: clinical medical fellow, Brigham and Women’s Hospital (1986-1989); medical oncology fellow, Dana-Farber Cancer Institute (1986-1989); clinical medical fellow, Harvard Medical School (1986-1989); chief medical resident (1985-1986) and medical resident (1983-1985), University of Washington Hospitals

Selected Honors, Awards, and Non-AACR Service: recipient, Giant of Cancer Care Award in Gastrointestinal Cancer, OncLive (2014); honoree, the one hundred, Massachusetts General Hospital Cancer Center (2014); recipient, Hope Funds for Cancer Research Award for Developmental Therapeutics (2010); recipient, American Italian Cancer Foundation Prize for Scientific Excellence in Medicine (2009); recipient, Alexander Bodini Foundation Prize for Scientific Excellence in Medicine (2009); recipient, Statesman Award, American Society of Clinical Oncology (2008); member, Scientific Advisory Board, Hope Funds for Cancer Research (2007); member, Scientific Advisory Board, Caring for Carcinoid Foundation (2006-2008); member, Scientific Advisory Board, Desmoid Tumor Research Foundation (2006-present); Recipient, Tisch Family Outstanding Achievement Award, Dana-Farber Cancer Institute (2005); recipient, Claire W. and Richard P. Morse Research Award, Dana-Farber Cancer Institute (2004); recipient, Emil J. Freireich Award in Clinical Cancer Research, MD Anderson Cancer Center (2002); cochairperson, Medical Advisory Board, Sarcoma Foundation of America (2001-present)

Selected AACR Service: member, Chemistry in Cancer Research Working Group (2014-present); member, AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Committee (2014); scientific editor, Cancer Discovery (2011-2014); member, Research Grant Review Committee (2012); cochairperson, Annual Meeting Program Committee (2011); chairperson, Translational Cancer Medicine Meeting (2010); co-organizer, educational workshop, “Translational Cancer Research for Basic Scientists” (2010-2014); member, Clinical and Translational Cancer Research Committee (2009-2013); member, Cancer Immunology Working Group (2008-present); member, Tumor Microenvironment Working Group (2008-present); member, Scientific Program Committee, AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (2000, 2008); member, Annual Meeting Education Committee (2007); member, Scientific Program Committee, AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development (2007); editorial board member, Molecular Cancer Therapeutics (2001-2003)

Education: MD, Stanford University School of Medicine, Stanford, California (1983); AB, biochemical sciences, Harvard College, Cambridge, Massachusetts (1978)

Submit your votes now.